Foreign Drug Makers Consider Japanese Market More Important Than Japanese Drug Companies

Executive Summary

According to a recent survey conducted by Booz & Company on the pharmaceutical industry for the next 10 years in Japan, 38 percent of foreign pharmaceutical companies operating in Japan consider the Japanese market very important to them. In contrast, 27 percent of Japanese major pharmaceutical companies and 18 percent of middle sized drug makers share the same view. Among the major Japanese drug makers, 36 percent plans to focus on overseas market. Out of 248 target foreign and Japanese domestic companies, 35 companies answered the survey. (Click here for more - Japanese language